Company intelligence

Metis TechBio

BiotechActive

Is this your company? Get featured or correct your listing →

Suggest a correction

We're still building this profile — here is what Pulse has covered.

Recent changes

  1. Oct 19, 2026Metis TechBio Inks Up To $1.1B Drug-Delivery Deal With Eli Lilly Pulse story

Latest Pulse

  1. Metis TechBio Inks Up To $1.1B Drug-Delivery Deal With Eli LillyHong Kong-listed Metis TechBio struck a collaboration with Eli Lilly worth up to $1.1 billion in milestone payments, using its AI-driven lipid nanoparticle platform to help Lilly's drugs reach specific tissues more precisely.→

Coverage Timeline

newest first
  1. Oct 19, 2026AIMetis TechBio Inks Up To $1.1B Drug-Delivery Deal With Eli LillyUp To $1.1B Deal→

All Coverage

AI

Metis TechBio Inks Up To $1.1B Drug-Delivery Deal With Eli Lilly

Illustration for: Metis TechBio Inks Up To $1.1B Drug-Delivery Deal With Eli Lilly
AIUp To $1.1B Deal

Metis TechBio Inks Up To $1.1B Drug-Delivery Deal With Eli Lilly

Hong Kong-listed Metis TechBio struck a collaboration with Eli Lilly worth up to $1.1 billion in milestone payments, using its AI-driven lipid nanoparticle platform to help Lilly's drugs reach specific tissues more precisely.

DEEP DIVE

Related Companies

Same sector
Scribe TherapeuticsAttovia TherapeuticsIambic TherapeuticsApnimedRetension PharmaceuticalsEli Lilly